A.M. Crawford - Concepedia

Author

A.M. Crawford

Eli Lilly (United States)

Also Known As

A M Crawford, A. Crawford, A.M. Crawford, A.M.K. Crawford, Ann Crawford, Ann Marie Crawford, Ann Marie K. Crawford

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

A.M. Crawford is an author at Eli Lilly (United States) specializing in medicine, psychopharmacology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	661
2	Psychiatry	5	5	474
3	Social Sciences	4	4	464
4	Pharmacology	2	2	201
5	Mental Health	2	2	169

A.M. Crawford

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Nancy U. Lin, Lisa A. Carey, Minetta C. Liu, Journal of Clinical Oncology	2008	459
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial Charles M. Beasley, S.H. Hamilton, A.M. Crawford, European Neuropsychopharmacology PsychiatryPsychotropic MedicationOlanzapine Versus HaloperidolPsychopharmacologySchizophrenia	1997	281
The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations A.M. Crawford, Charles M. Beasley, Gary D. Tollefson Schizophrenia Research Serum Prolactin ConcentrationsLong-term EffectPsychotropic MedicationPharmacologyNeuropharmacology	1997	187
Weight change and atypical antipsychotic treatment in patients with schizophrenia. B. Jones, Bruce R. Basson, Daniel Walker, PubMed ObesitySchizophrenic PatientsPsychiatryPsychotic DisorderMedicine	2001	90
Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand Oye Gureje, Wayne Miles, Nicholas A Keks, Schizophrenia Research PsychiatryRandomized Double-blind TrialPsychotropic MedicationPsychotic DisorderNew Zealand	2003	79
Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial. Juan Carlos Gómez, A.M. Crawford PubMed	2001	24
Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia Y. Lecrubier, M. Bouhassira, Véronique Olivier, European Neuropsychopharmacology PsychiatryPsychotic DisorderMedicinePsychotropic MedicationOlanzapine Versus Amisulpride	1999	14
Acute and long-term results of the dose ranging double-blind olanzapine trial P. Tran, Charles M. Beasley, G.D. Tollefson, European Neuropsychopharmacology Long-term ResultsPsychiatryPsychotropic MedicationPsychopharmacologyNeuropharmacology	1996	10

Page 1